Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Director/PDMR Shareholding

13 Feb 2026 13:11

RNS Number : 9984S
React Group PLC
13 February 2026
Β 

13 February 2026

Β 

REACT Group plc

("REACT", the "Group" or the "Company")

Β 

Director/PDMR Shareholding

Β 

REACT Group plc (AIM: REAT.L), the leading specialist support services provider to the FM industry, announces that on 13 February 2026, Spencer Dredge, Chief Financial Officer, purchased 8,000 ordinary shares of 12.5 pence each in the Company ("Ordinary Shares") at a price of 52.98 pence per Ordinary Share.

Β 

Following the purchase, Mr Dredge has an interest in 18,000 Ordinary Shares (excluding SIP purchases), representing 0.08% of the total issued share capital of the Company.

Β 

Further details are set out in the below notification, made in accordance with the requirements of the UK Market Abuse Regulation.Β 

Β 

For more information:

Β 

REACT Group

Tel: +44 (0) 1283 550 503

Shaun Doak, Chief Executive Officer

Spencer Dredge, Chief Financial Officer

Mark Braund, Chair

Singer Capital Markets - Nominated Adviser & Sole Broker

Tel: +44 (0) 207 496 3000

Philip Davies / Alex Bond / Carl Diebitsch

Β 

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Spencer Dredge

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

REACT Group PLC

b)

LEI

213800H54C4GOFN7MO32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 12.5 pence each

GB00BPCTRB97

b)

Nature of the transaction

Purchase of Ordinary Shares

Β 

c)

Price(s) and volume(s)

Β 

Price (pence)

Volume

52.98p

8,000

Β 

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

N/A - Single transaction

Β 

e)

Date of the transaction

13 February 2026Β 

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUORORNKUUAAR
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.